pubmed.ncbi.nlm.nih.gov El-Domyati M, et al
Keep it out of reach of children and pets
1 Major clinical trials have demonstrated that certain GLP-1 receptor agonists can significantly reduce the risk of major adverse cardiovascular events (MACE), such as heart attack, stroke, and cardiovascular death
Healthcare providers and advocacy groups warn that without affordable alternatives, many patients may be unable to continue their treatment, jeopardizing their progress and increasing the national obesity burden
Pharmacists can provide simple, actionable guidance to help patients better tolerate therapy
Purify His-tagged proteins by choosing agarose beads containing metal ions to perform immobilized metal affinity chromatography (IMAC)